Preclinical Results with If Current Inhibition by Ivabradine
- 1 January 2007
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 67 (Supplement) , 25-33
- https://doi.org/10.2165/00003495-200767002-00004
Abstract
Ivabradine, a highly selective Ifcurrent inhibitor acting directly on the sinoatrial node, induces a rapid, sustained and dose-dependent reduction of heart rate at rest and during exercise, without...Keywords
This publication has 30 references indexed in Scilit:
- Conversion of post-systolic wall thickening into ejectional thickening by selective heart rate reduction during myocardial stunningEuropean Heart Journal, 2007
- Heart rate reduction by inhibition of I f or by β-blockade has different effects on postsystolic wall thickeningBritish Journal of Pharmacology, 2007
- Use‐dependent inhibition of hHCN4 by ivabradine and relationship with reduction in pacemaker activityBritish Journal of Pharmacology, 2007
- The discovery of the selective If current inhibitor ivabradine: A new therapeutic approach to ischemic heart diseasePharmacological Research, 2006
- Anti-ischaemic effect of ivabradinePharmacological Research, 2006
- Efficacy of ivabradine, a new selective If inhibitor, compared with atenolol in patients with chronic stable anginaEuropean Heart Journal, 2005
- Bradycardia Induces Angiogenesis, Increases Coronary Reserve, and Preserves Function of the Postinfarcted HeartCirculation, 2004
- Effect of Graded Heart Rate Reduction with Ivabradine on Myocardial Oxygen Consumption and Diastolic Time in Exercising DogsThe Journal of Pharmacology and Experimental Therapeutics, 2004
- α1and α2‐adrenergic control of large and small coronary arteries during exercise in conscious dogs under β‐blockadeFundamental & Clinical Pharmacology, 1993
- Differential Effects of Celiprolol and Atenolol on Large Epicardial Coronary Arteries in Conscious Dogs at Rest and During ExerciseJournal of Cardiovascular Pharmacology, 1993